La regresión a la media en la investigación y práctica clínica

Medicina Clinica

Volumn 109, Issue 1, 1997, Pages 23-26

  Guallar, Eliseo ^a,c   Jiménez, F Javier ^a   García Alonso, Fernando ^a   Bakke, Olav M ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL MEDICINE; REGRESSION ANALYSIS; RESEARCH; STATISTICS;

CLINICAL MEDICINE; REGRESSION ANALYSIS; RESEARCH;

EID: 2442541981     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Galton F. Regression towards mediocrity in hereditary stature. J Anthropol Inst 1886; 15: 246-263.
2. Andersen B. Methodological errors in medical research. An incomplete catalogue. Oxford: Blackwell Scientific Publications, 1990.
3. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 1976; 104: 493-498.
4. McMahan CA. Regression toward the mean in a two-stage selection program. Am J Epidemiol 1982; 116: 394-401.
5. James KE. Regression toward the mean in uncontrolled clinical studies. Biometrics 1973; 29: 121-130.
6. Fleiss JL. The design and analysis of clinical experiments. Nueva York: John Wiley & Sons, 1982.
7. Gardner MJ, Heady JA. Some effect of within-person variability in epidemiological studies. J Chronic Dis 1973; 26: 781-795.
8. Ederer F. Serum cholesterol changes: effects of diet and regression toward the mean, J Chronic Dis 1972; 25: 277-289.
9. Gould BA, Mann S, Davies AB, Altman DG, Raftery EB. Does placebo lower blood-pressure? Lancet 1981; 2: 1.377-1.381.
10. Mancia G, Grassi G, Pomidossi G, Gregorini L, Bertinieri G, Parati G et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 2: 695-698.
11. Rosner B. Screening for hypertension-some statistical observations, J Chron Dis 1977; 30: 7-18,
12. Shepard DS, Finison LJ. Blood pressure reductions: correcting for regression to the mean. Prev Med 1983; 12: 304-317.
13. Amigo I, Herrera J. La hipertensión de bata blanca. Med Clin (Barc) 1994; 102: 64-66.
14. Høegholm A, Kristensen KS, Madsen NH, Svendsen TL. White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients. Am J Hypertension 1992; 5: 64-70.
15. Spector R, Park GD. Regression to the mean: a potential source of error in clinical pharmacological studies. Drug Intell Clin Pharm 1985; 19: 916-919.
16. McSherry CK, Ferstenberg H, Calhoun WF. Lahman E, Virshup M. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg 1985; 202: 59-63.
17. McDonald CJ, Mazzuca SA, McCabe GP. How much of the placebo «effect» is really statistical regression? Stat Med 1983; 2: 417-427.
18. Spiro HM, ed. Doctors, patients, and placebo. New Haven: Yale University Press. 1986.
19. Anónimo. Prevention of chronic bronchitis exacerbations with ambroxol (Mucosolvan Retard). An open, long-term, multicenter study in 5.635 patients. Respiration 1989; 55(Supl 1): 84-96.
20. Brodribb JM, Humphreys DM. Diverticular disease: three studies. Part II - treatment with bran. Br Med J 1976; 1: 425-428.
21. Elander G, Hermeren G. Placebo effect and randomized clinical trials. Theor Med 1995; 16: 171-182.
22. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982; 248: 1.465-1.477.
23. Thomas D, Stram D, Dwyer J. Exposure measurement error: influence on exposure-disease relationships and methods of correction. Annu Rev Publ Health 1993; 14: 69-93.